The immunomodulatory effects of endocrine therapy in breast cancer

Endocrine therapies with SERMs (selective estrogen receptor modulators) or SERDs (selective estrogen receptor downregulators) are standard therapies for patients with estrogen receptor (ER)-positive breast cancer. Multiple small molecule inhibitors targeting the PI3K-AKT-mTOR pathway or CDK4/6 have...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Huanhuan, Zhou, Jun, Chen, Hailong, Li, Jiaxin, Zhang, Chao, Jiang, Xia, Ni, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792133/
https://www.ncbi.nlm.nih.gov/pubmed/33413549
http://dx.doi.org/10.1186/s13046-020-01788-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792133/
https://www.ncbi.nlm.nih.gov/pubmed/33413549
http://dx.doi.org/10.1186/s13046-020-01788-4

Ejemplares similares